Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique

Abstract

Nodal dissemination in locally advanced rectal cancer occurs mainly in two directions: upward and lateral. Lateral node involvement has been demonstrated; however, lateral lymph node dissection (LLND) is not routinely performed in Western countries and the focus is more on neoadjuvant treatment regimens. The main reasons for this are the high morbidity associated with the operation and the uncertain oncological benefit. There is, however, recent evidence that in selected cases, neoadjuvant treatment combined with total mesorectal excision only might not be sufficient. In this article, the historical developments in the East and the West, the current evidence regarding lateral nodal disease, and the surgical steps in the LLND are discussed.

Keywords

rectal cancer - lateral nodes - local recurrence

• References

• 1 Gerota D. Die lymphgefasse des rectums und des anus. Arch Anat Physiol 1895; 181: 240
• 2 Miles WE. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908; 2: 1812-1813
• 3 Waugh JM, Kirklin JW. The importance of the level of the lesion in the prognosis and treatment of carcinoma of the rectum and low sigmoid colon. Ann Surg 1949; 129 (01) 22-33
• 4 Sunderland DA. The significance of vein invasion by cancer of the rectum and sigmoid; a microscopic study of 210 cases. Cancer 1949; 2 (03) 429-437
• 5 Wangensteen OH, Toon RW. Primary resection of the colon and rectum with particular reference to cancer and ulcerative colitis. Am J Surg 1948; 75 (02) 384-404
• 6 Villemin F. Recherches anatomiques sur les lymphatiques du rectum et l'anus: leur applications dans le traitement chirurgical du cancer. Rev Chir 1925; 63: 39-80
• 7 Oliviera E. Observacao sobre os linfaticos anoretais. Tese Rio de Janeiro 1947; 77
• 8 Coller FA, Kay EB, Macintyre RS. Regional lymphatic metastases of carcinoma of the colon. Ann Surg 1941; 114 (01) 56-67
• 9 Dukes CE. The surgical pathology of rectal cancer: president's address. Proc R Soc Med 1944; 37 (04) 131-144
• 10 Sauer I, Bacon HE. Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis. Am J Surg 1951; 81 (01) 111-120
• 11 Stearns Jr MW, Deddish MR. Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum 1959; 2 (02) 169-172
• 12 Enker WE, Pilipshen SJ, Heilweil ML. , et al. En bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of rectal cancer. Ann Surg 1986; 203 (04) 426-433
• 13 Glass RE, Ritchie JK, Thompson HR, Mann CV. The results of surgical treatment of cancer of the rectum by radical resection and extended abdomino-iliac lymphadenectomy. Br J Surg 1985; 72 (08) 599-601
• 14 Michelassi F, Block GE. Morbidity and mortality of wide pelvic lymphadenectomy for rectal adenocarcinoma. Dis Colon Rectum 1992; 35 (12) 1143-1147
• 15 Senba Y. An anatomical study of the lymphatic system of the rectum. J Fukuoka Med Coll 1927; 20: 1213-1268
• 16 Kuru M. Cancer of the rectum. J Jpn Surg Soc 1940; 41: 832-877
• 17 Koyama Y. Extended surgery for rectal cancer (Japanese). Geka Chiryo 1977; 36: 41-45
• 18 Hojo K, Koyama Y. Postoperative follow-up studies on cancer of the colon and rectum. Am J Surg 1982; 143 (03) 293-303
• 19 Hojo K, Sawada T, Moriya Y. An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum 1989; 32 (02) 128-133
• 20 Sato K, Sato T. The vascular and neuronal composition of the lateral ligament of the rectum and the rectosacral fascia. Surg Radiol Anat 1991; 13 (01) 17-22
• 21 Hojo K, Vernava III AM, Sugihara K, Katumata K. Preservation of urine voiding and sexual function after rectal cancer surgery. Dis Colon Rectum 1991; 34 (07) 532-539
• 22 Moriya Y, Sugihara K, Akasu T, Fujita S. Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer. Eur J Cancer 1995; 31A (7-8): 1229-1232
• 23 Moriya Y, Sugihara K, Akasu T, Fujita S. Patterns of recurrence after nerve-sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence. Dis Colon Rectum 1995; 38 (11) 1162-1168
• 24 Sugihara K, Moriya Y, Akasu T, Fujita S. Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome. Cancer 1996; 78 (09) 1871-1880
• 25 Mori T, Takahashi K, Yasuno M. Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg 1998; 383 (06) 409-415
• 26 Matsumoto T, Ohue M, Sekimoto M, Yamamoto H, Ikeda M, Monden M. Feasibility of autonomic nerve-preserving surgery for advanced rectal cancer based on analysis of micrometastases. Br J Surg 2005; 92 (11) 1444-1448
• 27 Sugihara K, Kobayashi H, Kato T. , et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 2006; 49 (11) 1663-1672
• 28 Nagawa H, Muto T, Sunouchi K. , et al. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 2001; 44 (09) 1274-1280
• 29 Watanabe T, Tsurita G, Muto T. , et al. Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery 2002; 132 (01) 27-33
• 30 Kim JC, Takahashi K, Yu CS. , et al. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg 2007; 246 (05) 754-762
• 31 Watanabe T, Matsuda K, Nozawa K, Kobunai T. Lateral pelvic lymph node dissection or chemoradiotherapy: which is the procedure of choice to reduce local recurrence rate in lower rectal cancer?. Ann Surg 2008; 248 (02) 342-343 , author reply 343
• 32 Kapiteijn E, Kranenbarg EK, Steup WH. , et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur J Surg 1999; 165 (05) 410-420
• 33 Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B. ; Stockholm Colorectal Cancer Study Group. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001; 92 (04) 896-902
• 34 General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. 7th ed. Japanese Research Society for Cancer of the Colon and Rectum. 2006
• 35 Najarian MM, Belzer GE, Cogbill TH, Mathiason MA. Determination of the peritoneal reflection using intraoperative proctoscopy. Dis Colon Rectum 2004; 47 (12) 2080-2085
• 36 Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol 2003; 4 (11) 695-702
• 37 Maas CP, Moriya Y, Steup WH, Klein Kranenbarg E, van de Velde CJ. A prospective study on radical and nerve-preserving surgery for rectal cancer in the Netherlands. Eur J Surg Oncol 2000; 26 (08) 751-757
• 38 Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312 (25) 1604-1608
• 39 Steup WH. Chapter 6: Historical comparison Japanese data NCCH; Comparison between Japan and the Netherlands. Thesis: Colorectal cancer surgery with emphasis on lymphadenectomy. 1994: 83-100
• 40 Kusters M, Beets GL, van de Velde CJ. , et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg 2009; 249 (02) 229-235
• 41 Fujita S, Akasu T, Mizusawa J. , et al; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol 2012; 13 (06) 616-621
• 42 Fujita S, Mizusawa J, Kanemitsu Y. , et al. A randomized trial comparing mesorectal excision with or without lateral lymph node dissection for clinical stage II, III lower rectal cancer: Primary endpoint analysis of Japan Clinical Oncology Group study JCOG0212. J Clin Oncol 2016; 34 (15) 3508
• 43 Kim TH, Jeong SY, Choi DH. , et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2008; 15 (03) 729-737
• 44 Kim TG, Park W, Choi DH. , et al. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients. Int J Colorectal Dis 2014; 29 (02) 193-200
• 45 Kim MJ, Kim TH, Kim DY. , et al. Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer?. J Surg Oncol 2015; 111 (04) 459-464
• 46 Lim SB, Yu CS, Kim CW. , et al. Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy. Int J Colorectal Dis 2013; 28 (12) 1667-1674
• 47 Oh HK, Kang SB, Lee SM. , et al. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol 2014; 21 (07) 2280-2287
• 48 Akiyoshi T, Ueno M, Matsueda K. , et al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 2014; 21 (01) 189-196
• 49 Akiyoshi T, Matsueda K, Hiratsuka M. , et al. Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer. Ann Surg Oncol 2015; 22 (Suppl. 03) S614-S620